A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth.
about
Mesenchymal stem cell therapy in type 2 diabetes mellitus.Articles in 'endocrinology and metabolism' in 2014Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin SignalingDevelopment of Spexin-based Human Galanin Receptor Type II-Specific Agonists with Increased Stability in Serum and Anxiolytic Effect in Mice.Evolutionary and Comparative Genomics to Drive Rational Drug Design, with Particular Focus on Neuropeptide Seven-Transmembrane Receptors.
P2860
A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A Novel Long-Acting Glucagon-L ...... n Secretion and β-Cell Growth.
@ast
A Novel Long-Acting Glucagon-L ...... n Secretion and β-Cell Growth.
@en
A Novel Long-Acting Glucagon-L ...... n Secretion and β-Cell Growth.
@nl
type
label
A Novel Long-Acting Glucagon-L ...... n Secretion and β-Cell Growth.
@ast
A Novel Long-Acting Glucagon-L ...... n Secretion and β-Cell Growth.
@en
A Novel Long-Acting Glucagon-L ...... n Secretion and β-Cell Growth.
@nl
prefLabel
A Novel Long-Acting Glucagon-L ...... n Secretion and β-Cell Growth.
@ast
A Novel Long-Acting Glucagon-L ...... n Secretion and β-Cell Growth.
@en
A Novel Long-Acting Glucagon-L ...... n Secretion and β-Cell Growth.
@nl
P2093
P2860
P1476
A Novel Long-Acting Glucagon-L ...... n Secretion and β-Cell Growth.
@en
P2093
Hee Young Kim
Jae Young Seong
Jong-Ik Hwang
Mi Jin Moon
P2860
P304
P356
10.3803/ENM.2014.29.3.320
P577
2014-09-25T00:00:00Z